The itching started when she was fifty-one. She assumed thrush and treated it. It came back. She treated it again, then tried a different cream, then stopped using soap, then changed her washing powder.
By fifty-five it was waking her at night. Sex had become painful in a way that felt like tearing rather than dryness. She had seen three different doctors and been given antifungals twice, a steroid cream once with no instructions, and reassurance that it was probably the menopause.
She is not unusual. In UK research, the average delay from first symptom to diagnosis of vulval lichen sclerosus is 4.6 years, and the longest self-reported delay was 51 years.
This matters more than most delayed diagnoses, because the damage this condition does while waiting is permanent, and the treatment that stops it is a cream.
It is a chronic inflammatory skin condition, with a strong preference for the vulval and anal area, in which the immune system attacks the skin. Most researchers now classify it as autoimmune.
The skin becomes thin, fragile and pale, often described as looking white, crinkled or like tissue paper. It splits easily. Over time, and this is the part that matters, the inflammation causes scarring that changes the anatomy.
The labia minora can flatten and fuse into the surrounding tissue. The clitoral hood can seal over. The vaginal opening can narrow. These changes are structural, and once they have happened they do not reverse with treatment.
That single fact is why a diagnostic delay of five years is not merely frustrating.
It affects up to 3 per cent of women, though the true figure is unknown because misdiagnosis and underdiagnosis are so widely reported.
Three per cent means roughly one woman in thirty. It is more common than most people assume and considerably more common than the number diagnosed.
The age pattern is bimodal, with peaks before puberty and after menopause, though a Danish study published in 2026 found peaks in the twenties and fifties. Around 20 per cent of affected women develop it before perimenopause, which is why being young is not a reason to dismiss it.
Four reasons, and understanding them tells you what to do differently.
It looks like thrush at first glance, and thrush is what gets treated. Repeated antifungals that do not work is one of the most reliable clues that something else is going on.
It gets attributed to menopause. Itching, dryness and painful sex are all expected at this age, so they get absorbed into the general category of menopausal change and treated with lubricant or oestrogen.
Nobody looks. Diagnosis is usually clinical, made by examining the vulva. If no examination happens, no diagnosis happens. Research into barriers in primary care identifies this repeatedly.
Women delay too. Embarrassment about genital symptoms is real, and many women try everything available over the counter before mentioning it to anyone.
The Danish study captured the resulting picture starkly: many patients remained undiagnosed after more than seven years of symptoms, having passed through multiple consultations with different doctors.
Itching is the dominant symptom, often worse at night, often severe enough to disturb sleep. Women describe it as maddening rather than mild.
Soreness, burning or stinging, particularly after washing or during urination if the skin has split.
Skin that splits or tears, especially with sex, and often in the same place repeatedly.
Pain during sex that feels like tearing at the entrance rather than internal dryness.
Visible changes: pale or white patches, skin that looks thin, shiny or crinkled, sometimes bruising or small blood blisters.
Difficulty passing urine or a stream that has changed direction, if the anatomy has altered.
Some women have no symptoms at all and it is found incidentally.
The pattern that should raise the question: itching that recurs, does not respond to antifungals, is worse at night, and comes with visible pale skin changes.
Thrush causes itching and soreness, usually with discharge, and it responds to antifungal treatment. Lichen sclerosus does not.
Vaginal atrophy from falling oestrogen causes dryness, thinning and painful sex. But the skin does not go white or crinkled, it does not split repeatedly in the same place, and the anatomy does not fuse. It also responds to local oestrogen, which lichen sclerosus does not. Vaginal dryness and intimacy covers that condition.
Eczema or contact dermatitis is usually more red than white and improves when the irritant is removed.
Lichen planus is a related condition affecting the vagina as well as the vulva, and can involve the mouth.
The clearest discriminator: if local oestrogen and antifungals have both failed, the diagnosis is probably neither of the things they treat.
Ultra-potent topical steroid, usually clobetasol propionate 0.05 per cent, is the established treatment and it works well. Around 60 to 70 per cent of women achieve complete remission of symptoms after a three-month course applied once daily.
Women are often frightened of steroids on delicate skin, and that fear causes real harm here. Under-treatment is a much bigger problem than over-treatment. Used as directed, the risk of skin thinning is low, and the disease itself thins the skin far more than the treatment does.
Two things matter about how it is used.
It needs proper instructions. How much, where exactly, how often, and for how long. A tube handed over without explanation is a common reason treatment fails.
It continues after symptoms settle. Maintenance, typically once or twice a week, is standard. Lichen sclerosus is chronic; stopping when the itching goes usually means it returns.
Emollients help alongside, soap should be avoided on the area entirely, and local oestrogen may be used in addition if there is also atrophy, though it does not treat the lichen sclerosus itself.
This needs stating carefully, because it is frightening and frequently either exaggerated or omitted.
Lichen sclerosus is associated with an increased risk of vulval cancer. A systematic review of 14 studies covering 14,030 women without previous vulval neoplasia found vulval cancer in 2.2 per cent.
So the risk is real, and it is small: roughly one in forty-five over the periods studied.
Two things reduce it, and both are within your control.
Treatment. The same review found the risk was significantly decreased with ultrapotent topical steroid use. Treating it properly is not only about comfort.
Monitoring. Review every six to twelve months, and prompt assessment of any lump, ulcer, thickened patch or area that will not heal. Risk is highest in the first few years after diagnosis and rises with age.
The honest summary: this is a reason to treat and be reviewed, not a reason to panic. Women who use their steroid properly and attend follow-up are doing the two things that matter.
Ask for an examination. This is the single step that changes everything, and it will not happen unless someone looks. A reasonable sentence: "I have persistent vulval itching that has not responded to thrush treatment. Could you examine me and consider lichen sclerosus?"
Say what has already failed. Repeated antifungals that did not work, and local oestrogen that did not work, are both diagnostic information.
Mention the specific features: pale or white skin, splitting in the same place, itching worse at night, any change in shape.
Ask for referral if you are not examined, or if treatment does not help within three months. Vulval clinics exist and this is what they are for.
Do not accept lubricant alone as an answer if the skin is changing colour or texture. Lubricant treats friction; it does not treat inflammation.
Lichen sclerosus is common enough that most women will know someone with it, and rare enough in conversation that almost nobody has heard of it.
It is diagnosed by looking. It is treated with a cream that puts most women into remission in three months. And every year of delay carries a risk of scarring that no treatment reverses.
If you have been treating recurrent thrush for two years and it keeps coming back, that is not thrush. Ask to be examined.
What is lichen sclerosus?
A chronic inflammatory, probably autoimmune, skin condition mainly affecting the vulval and anal area. The skin becomes thin, pale and fragile, and over time inflammation causes scarring that permanently alters the anatomy.
How common is it?
It affects up to 3 per cent of women, roughly one in thirty, though the true prevalence is unknown because misdiagnosis and underdiagnosis are widespread.
Why does it take so long to diagnose?
UK research found an average delay of 4.6 years. It is mistaken for thrush, attributed to menopause, and frequently missed because no examination takes place. Embarrassment adds further delay.
Is it the same as vaginal dryness from menopause?
No. Atrophy causes thinning and dryness but not white crinkled skin, repeated splitting or fusion of the anatomy, and it responds to local oestrogen. If oestrogen has not helped, that is a clue.
Is the steroid cream safe to use long term?
Yes, used as directed. Under-treatment causes far more harm than the cream does, and the condition itself damages skin more than the steroid. Maintenance once or twice weekly is standard practice.
Does lichen sclerosus cause cancer?
It is associated with increased risk of vulval cancer, found in around 2.2 per cent of women in a large systematic review. Ultrapotent topical steroid use significantly reduces that risk, which is why treatment and regular review matter.
Will it go away?
It is chronic rather than curable, but highly treatable. Around 60 to 70 per cent of women achieve complete symptom remission with three months of treatment, and maintenance keeps it controlled.
Sources: Bercaw-Pratt JL et al., and Kirtschig G et al., Evidence- and consensus-based S3 guideline on lichen sclerosus, J Dtsch Dermatol Ges 2026 · Systematic review of the barriers to diagnosis of vulval lichen sclerosus in primary care, Clin Exp Dermatol 2026;51:929-38 · Epidemiology of lichen sclerosus in women: findings from the Danish Skin Cohort, JAAD Int 2026 · Voss FO et al., Risk of development of vulvar cancer in women with lichen sclerosus or lichen planus: a systematic review, J Low Genit Tract Dis 2022;26(3):250-7 · Lee A, Bradford J, Fischer G, Long-term management of adult vulvar lichen sclerosus: a prospective cohort study of 507 women, JAMA Dermatol 2015;151(10):1061-7 · Educational only, not medical advice. Persistent vulval symptoms should be examined by a doctor.
Keep reading: Vaginal dryness and intimacy · Painful sex · Itchy skin in menopause · Menopause or autoimmune? · Bladder changes in menopause · Take the free Hormone Quiz